Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Press release - intarcia announces FDA filing acceptance of new drug application (NDA) for ITCA 650 for the treatment of type 2 diabetes
Dehydration is another consideration, particularly if patients experience gastrointestinal side effects such as vomiting or diarrhoea
Synergistic Amplification CJC-1295 ipamorelin research demonstrates that simultaneous GHRH-R and GHS-R activation can produce synergistic GH release exceeding the sum of individual responses
With the large patient pool of China, coupled with the increasing prevalence of metabolic diseases, Innovent is strategically positioning itself to become a major player in the market
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
